KLC2 Protein (Transcript Variant 4) (Myc-DYKDDDDK Tag)
-
- Target See all KLC2 Proteins
- KLC2 (Kinesin Light Chain 2 (KLC2))
- Protein Type
- Recombinant
- Protein Characteristics
- Transcript Variant 4
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This KLC2 protein is labelled with Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Characteristics
-
- Recombinant human KLC2 (transcript variant 4) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Purity
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product KLC2 Protein
-
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Comment
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- KLC2 (Kinesin Light Chain 2 (KLC2))
- Alternative Name
- Klc2 (KLC2 Products)
- Synonyms
- MGC143149 Protein, wu:fc15b01 Protein, wu:fj62c06 Protein, zgc:162288 Protein, DKFZp459K0951 Protein, 8030455F02Rik Protein, AW212649 Protein, KLC 2 Protein, KLC-2 Protein, kinesin light chain 2 Protein, KLC2 Protein, klc2 Protein, Klc2 Protein
- Background
- The protein encoded by this gene is a light chain of kinesin, a molecular motor responsible for moving vesicles and organelles along microtubules. Defects in this gene are a cause of spastic paraplegia, optic atrophy, and neuropathy (SPOAN) syndrome.
- Molecular Weight
- 68.8 kDa
- NCBI Accession
- NP_001128248
-